Loyal portfolio

Ignota Labs logo

Ignota Labs

Health · UK

Follow OnUKINSEAD
Sam Windsor

Sam Windsor

About Ignota Labs

Ignota Labs is an AI drug turnaround company. They use cutting-edge explainable AI to understand toxic liabilities of drugs which have failed during development. They use these novel insights to acquire those drugs with hidden potential, fix the liability and sell them on, bringing new hope to patients.

Visit website

In the news

  • Oct 14

    Ignota Labs contributes a talk, track support, and an entrepreneurship panelist to ELRIG Drug Discovery 2026.

    View on LinkedIn
  • Oct 13

    Ignota Labs attends ELRIG’s Drug Discovery 2026 in London to discuss trial failures, drug turnaround, and partnerships.

    View on LinkedIn
  • Oct 8

    Ignota Labs co-founder Layla Hosseini-Gerami speaks at BioTechX about AI drug discovery and women in leadership.

    View on LinkedIn
  • Oct 2

    Ignota Labs spotlights co-founder Layla Hosseini-Gerami as a speaker at an upcoming biotech founders webinar.

    View on LinkedIn
  • Sep 25

    Ignota Labs shares lessons on AI agents, human oversight, and building trust in discoveries from Anthropic’s ART preprint.

    View on LinkedIn

Founder

  • Sam Windsor

    Sam Windsor

Details

Stage
Follow On
Sector
Health
Country
UK
Region
UK
Source
INSEAD